{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:37Z","timestamp":1786986817731,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Journal of Traumatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cjtee.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T17:26:57Z","timestamp":1687627617000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of ABCB1 gene polymorphisms rs1128503, rs2032582, rs4148738 with anemia in patients receiving dabigatran after total knee arthroplasty"],"prefix":"10.1016","volume":"27","author":[{"given":"Alina","family":"Kasimova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Labutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Gvozdetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Bozhkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjtee.2023.06.003_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79490-w","article-title":"Venous thromboembolism in patients hospitalized for knee joint replacement surgery","volume":"10","author":"Keller","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjtee.2023.06.003_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.sart.2019.01.004","article-title":"Venous thromboembolism after total joint arthroplasty: risk stratification and prophylaxis","volume":"29","author":"Kang","year":"2019","journal-title":"Semin Arthroplasty"},{"key":"10.1016\/j.cjtee.2023.06.003_bib3","first-page":"1192","article-title":"Role of pharmacogenomics in the management of traditional and novel oral anticoagulants","volume":"31","author":"Cavallari","year":"2012","journal-title":"Pharma"},{"key":"10.1016\/j.cjtee.2023.06.003_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-10-14","article-title":"A\u00a012-month review of a modified protocol using low dose Dabigatran Etexilate in postoperative thromboembolic prophylaxis in joint replacement surgery","volume":"10","author":"Subramanian","year":"2012","journal-title":"Thromb J"},{"key":"10.1016\/j.cjtee.2023.06.003_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12306-013-0306-8","article-title":"Practical management of new oral anticoagulants after total hip or total knee arthroplasty","volume":"97","author":"Klauser","year":"2013","journal-title":"Musculoskelet Surg"},{"key":"10.1016\/j.cjtee.2023.06.003_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1586\/erc.12.15","article-title":"Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor","volume":"10","author":"Garza","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cjtee.2023.06.003_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/11587290-000000000-00000","article-title":"A\u00a0benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery","volume":"34","author":"Schulman","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.cjtee.2023.06.003_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/dmd.113.053769","article-title":"In\u00a0vitro predictability of drug-drug interaction likelihood of P-Glycoprotein-Mediated efflux of dabigatran etexilate based on [I]2\/IC50 threshold","volume":"42","author":"Kishimoto","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cjtee.2023.06.003_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cpt.1213","article-title":"Dabigatran etexilate and digoxin: comparison as clinical probe substrates for evaluation of P-gp inhibition","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjtee.2023.06.003_bib10","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/1076029609343004","article-title":"Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor","volume":"15","author":"Stangier","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.cjtee.2023.06.003_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.cjtee.2023.06.003_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.clpt.6100052","article-title":"ABCB1 pharmacogenetics: progress, pitfalls, and promise","volume":"81","author":"Chinn","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjtee.2023.06.003_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cjtee.2023.06.003_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40262-015-0267-1","article-title":"Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature","volume":"54","author":"Wolking","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cjtee.2023.06.003_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/tpj.2011.16","article-title":"An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics","volume":"11","author":"Wolf","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.cjtee.2023.06.003_bib16","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug- resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in\u00a0vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjtee.2023.06.003_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.tpj.6500413","article-title":"ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research","volume":"7","author":"Leschziner","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.cjtee.2023.06.003_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2141.2002.03588.x","article-title":"Reduced function of the multidrug resistance P-glycoprotein in CD34 + cells of patients with aplastic anaemia: P-gp Function in Aplastic Anaemia CD34 + Cells","volume":"118","author":"Calado","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cjtee.2023.06.003_bib19","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood\u2013brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA","volume":"115","author":"Bartels","year":"2008","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.cjtee.2023.06.003_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.23876\/j.krcp.18.0134","article-title":"Renal tubular P-glycoprotein expression is reduced in plasma cell disorders","volume":"38","author":"Heybeli","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.cjtee.2023.06.003_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/jpm11010037","article-title":"Pharmacogenetics of direct oral anticoagulants: a systematic review","volume":"11","author":"Raymond","year":"2021","journal-title":"J\u00a0Personalized Med"},{"key":"10.1016\/j.cjtee.2023.06.003_bib22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.112.001233","article-title":"Genetic determinants of dabigatran plasma levels and their relation to bleeding","volume":"127","author":"Par\u00e9","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjtee.2023.06.003_bib23","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.2174\/1381612824666181018153641","article-title":"Effect of ABCB1 genotypes on the pharmacokinetics and clinical outcomes of new oral anticoagulants: a systematic review and meta-analysis","volume":"24","author":"Xie","year":"2018","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.cjtee.2023.06.003_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/PGPM.S169277","article-title":"The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty","volume":"11","author":"Sychev","year":"2018","journal-title":"Pharmacogenomics Personalized Med"},{"key":"10.1016\/j.cjtee.2023.06.003_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/jth.13577","article-title":"Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB genetic polymorphisms and interaction with clarithromycin","volume":"15","author":"Gouin-Thibault","year":"2017","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.cjtee.2023.06.003_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040336","article-title":"Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study","volume":"11","author":"van der Veen","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjtee.2023.06.003_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.seminhematol.2015.07.006","article-title":"Anemia in clinical practice\u2014definition and classification: does hemoglobin change with aging?","volume":"52","author":"Cappellini","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cjtee.2023.06.003_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7861\/clinmedicine.14-2-165","article-title":"The newer direct oral anticoagulants: a practical guide","volume":"14","author":"Thachil","year":"2014","journal-title":"Clin Med"},{"issue":"6","key":"10.1016\/j.cjtee.2023.06.003_bib29","first-page":"575","volume":"20","author":"Vazquez","year":"2015","journal-title":"Direct oral anticoagulants (DOACs)"},{"key":"10.1016\/j.cjtee.2023.06.003_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11239-013-0967-z","article-title":"The pharmacology of novel oral anticoagulants","volume":"37","author":"DeWald","year":"2014","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.cjtee.2023.06.003_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2217\/pme-2017-0092","article-title":"Pharmacogenetics of novel oral anticoagulants: a review of identified gene variants & future perspectives","volume":"15","author":"A\u0161i\u0107","year":"2018","journal-title":"Pers Med"},{"key":"10.1016\/j.cjtee.2023.06.003_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/jpm9010007","article-title":"Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants","volume":"9","author":"Kanuri","year":"2019","journal-title":"J\u00a0Personalized Med"},{"key":"10.1016\/j.cjtee.2023.06.003_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.fpc.0000197467.21964.67","article-title":"Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance","volume":"16","author":"Leschziner","year":"2006","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.cjtee.2023.06.003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2016.05.025","article-title":"Pharmacogenetics of dabigatran etexilate interindividual variability","volume":"144","author":"Dimatteo","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjtee.2023.06.003_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/PGPM.S291723","article-title":"The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics in healthy Chinese subjects","volume":"14","author":"Liu","year":"2021","journal-title":"Pharmacogenomics Personalized Med"},{"key":"10.1016\/j.cjtee.2023.06.003_bib36","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jse.2019.11.029","article-title":"Therapeutic postoperative anticoagulation is a risk factor for wound complications, infection, and revision after shoulder arthroplasty","volume":"29","author":"Cancienne","year":"2020","journal-title":"J\u00a0Shoulder Elbow Surg"},{"key":"10.1016\/j.cjtee.2023.06.003_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.arth.2018.08.034","article-title":"Persistent wound drainage after total joint arthroplasty: a narrative review","volume":"34","author":"Wagenaar","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.cjtee.2023.06.003_bib38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.arth.2012.07.033","article-title":"Hematoma following primary total hip arthroplasty: a grave complication","volume":"28","author":"Mortazavi","year":"2013","journal-title":"J\u00a0Arthroplasty"}],"container-title":["Chinese Journal of Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1008127523000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1008127523000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:17:48Z","timestamp":1760883468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1008127523000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1008127523000640"],"URL":"https:\/\/doi.org\/10.1016\/j.cjtee.2023.06.003","relation":{},"ISSN":["1008-1275"],"issn-type":[{"value":"1008-1275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of ABCB1 gene polymorphisms rs1128503, rs2032582, rs4148738 with anemia in patients receiving dabigatran after total knee arthroplasty","name":"articletitle","label":"Article Title"},{"value":"Chinese Journal of Traumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjtee.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Chinese Medical Association. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}